clinical
-
Biologics
BBS-Bioactive Bone Substitutes Plc: We are pleased to announce that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft
19.2.2020 The clinical investigation run by BBS-Bioactive Bone Substitutes Oyj in clinical centers in Finland and Poland has been finalized…
Read More » -
Financial
Embody, Inc. Extends DARPA Funding to $14.35 Million
NORFOLK, Va., Jan. 14, 2020 /PRNewswire/ —Embody, Inc., a privately-held medical device company focused on soft tissue repair, announced today they have…
Read More » -
Spine
First Clinical Publication in Japan for the SpineGuard DSG® Technology
December 16, 2019 PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory News: SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG®…
Read More » -
Biologics
Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs
October 14, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated company, focused on developing regenerative therapies leveraging its…
Read More » -
Biologics
Early data demonstrate motor function improvement for spinal cord stem cell treatment
26th January 2017 A new therapy to treat spinal cord injuries in people who have lost all motor and sensory…
Read More » -
Extremities
Bioness StimRouter™ Neuromodulation System Clinical Data Presented At The 2017 North American Neuromodulation Society’s Annual Meeting
VALENCIA, Calif., Jan. 20, 2017 /PRNewswire/ — Bioness, Inc., the leading provider of state-of-the-art, clinically supported rehabilitation and pain management medical devices,…
Read More » -
Sports Medicine
Histogenics Announces Publication of MRI Data From NeoCart® Phase 1 and Phase 2 Clinical Trials in the American Journal of Sports Medicine
WALTHAM, Mass., Jan. 11, 2017 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (HSGX), a regenerative medicine company focused on developing and…
Read More » -
Biologics
InVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital
January 10, 2017 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Rhode Island Hospital in Providence, RI has been…
Read More » -
Biologics
SpinalCyte, LLC Receives Institutional Review Board Approval for Phase I Clinical Trial
December 13, 2016 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus…
Read More » -
Spine
Implanet Presents JAZZ Band Clinical Results in Hypokyphotic Idiopathic Scoliosis Patients
December 06, 2016 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical…
Read More » -
Spine
Clinical and retrieval evidence for corrosion of spine implants
All prosthetic implants are subject to some degree of wear and corrosion in the body. Wear is a mechanical process…
Read More » -
Biologics
Asterias Biotherapeutics Announces Treatment of First Spinal Cord Injury Patient with Maximum Dose of AST-OPC1 in SCiStar Clinical Trial
FREMONT, Calif., Nov. 8, 2016 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine,…
Read More » -
Spine
Dr. Kern Singh to Lead a Clinical Study on the FLXfit™ 3D Expandable Cage at Rush University Medical Center
OR AKIVA, Israel, October 27, 2016 /PRNewswire/ — Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on…
Read More » -
Spine
Life Spine® Announces Initial Clinical Cases with PRO-LINK® Ti Stand-Alone Cervical Spacer System
October 26, 2016 – HUNTLEY, Ill.–(BUSINESS WIRE)– Life Spine, a medical device company that designs, develops, manufactures and markets products…
Read More » -
Recon
ConforMIS Announces Clinical Study iTotal CR Customized Implants better approximate knee motion compared to Off-the-Shelf Total Knee Implant
BEDFORD, Mass., October 17, 2016 (GLOBE NEWSWIRE) – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells…
Read More »